Zilebesiran in Hypertension: Reversibility, Acute Illness, and Therapeutic Flexibility

Lucas Maciel de Almeida Corrêa, Gabriel Rian Mazur, Clara Belo Gamon Santiago, Alexandre de Assis Barbosa, Ivan Felipe Dutra Júnior, Gabriel Costa de Santana, Luiggi Kevin Virgino Brandão, Yan Roberth Delmiro Silva, Letícia Esteves Dante

Open source

DOI: 10.1007/s40256-026-00823-7
Published: 2026-08-17
Container: American Journal of Cardiovascular Drugs
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40256-026-00823-7,
  title = {Zilebesiran in Hypertension: Reversibility, Acute Illness, and Therapeutic Flexibility},
  author = {Lucas Maciel de Almeida Corrêa and Gabriel Rian Mazur and Clara Belo Gamon Santiago and Alexandre de Assis Barbosa and Ivan Felipe Dutra Júnior and Gabriel Costa de Santana and Luiggi Kevin Virgino Brandão and Yan Roberth Delmiro Silva and Letícia Esteves Dante},
  year = {2026},
  journal = {American Journal of Cardiovascular Drugs},
  doi = {10.1007/s40256-026-00823-7},
  url = {https://doi.org/10.1007/s40256-026-00823-7}
}

RIS

TY  - JOUR
TI  - Zilebesiran in Hypertension: Reversibility, Acute Illness, and Therapeutic Flexibility
AU  - Lucas Maciel de Almeida Corrêa
AU  - Gabriel Rian Mazur
AU  - Clara Belo Gamon Santiago
AU  - Alexandre de Assis Barbosa
AU  - Ivan Felipe Dutra Júnior
AU  - Gabriel Costa de Santana
AU  - Luiggi Kevin Virgino Brandão
AU  - Yan Roberth Delmiro Silva
AU  - Letícia Esteves Dante
PY  - 2026
JO  - American Journal of Cardiovascular Drugs
DO  - 10.1007/s40256-026-00823-7
UR  - https://doi.org/10.1007/s40256-026-00823-7
ER  -

APA

Corrêa, L. M. D. A., Mazur, G. R., Santiago, C. B. G., Barbosa, A. D. A., Júnior, I. F. D., Santana, G. C. D., Brandão, L. K. V., Silva, Y. R. D., & Dante, L. E. (2026). Zilebesiran in Hypertension: Reversibility, Acute Illness, and Therapeutic Flexibility. American Journal of Cardiovascular Drugs. https://doi.org/10.1007/s40256-026-00823-7

Source records

crossref · retrieved 2026-11-11T01:46:48.271Z